Nervous system

Streamba Unveils Supply Chain Solution with Shell's Inventory Optimization Technology Application

Retrieved on: 
Monday, March 4, 2024
United States corporate law, Nervous system, GM, Supply, History, Shell, Software as a service, Shell plc, Partnership

GLASGOW, Scotland, March 4, 2024 /PRNewswire-PRWeb/ -- Supply Chain Software-as-a-Service (SaaS) business, Streamba, is excited to announce a licensing agreement for Shell's Inventory Optimization Technology Application. Already servicing 80% of their assets globally, this technology has helped Shell reduce material and equipment redundancy. Streamba will now take this solution to the open market, as part of its Supply Chain and Logistics platform, VOR, named after the Norse goddess of wisdom.

Key Points: 
  • GLASGOW, Scotland, March 4, 2024 /PRNewswire-PRWeb/ -- Supply Chain Software-as-a-Service (SaaS) business, Streamba, is excited to announce a licensing agreement for Shell's Inventory Optimization Technology Application.
  • "We are thrilled to collaborate with Shell to commercialise their Inventory Optimization Technology Application, helping businesses navigate the challenges facing global supply chains."
  • Making Shell's Inventory Optimization Technology Application available on Streamba's VOR platform broadens visibility within the complex supply chain underpinning major capital projects.
  • "We are thrilled to collaborate with Shell to commercialise their Inventory Optimization Technology Application," said Steven Calder, CEO of Streamba.

Sleep Apnea Symptoms Linked to Memory and Thinking Problems

Retrieved on: 
Monday, March 4, 2024
Social media, Nervous system, Alzheimer's disease, Boston Medical Center, CPAP, Dementia, Education, Sleep apnea, Blood, Quality of life, Thought, Sleep, Continuous positive airway pressure, Stroke, Confusion, Risk, Annual general meeting, DSM-IV codes, Migraine, AAN, Multiple sclerosis, Parkinson's disease, Memory, Concussion, MPH, Headache, Epilepsy, Brain, Research, American Academy, Pharmaceutical industry

"Our study found participants who had sleep apnea symptoms had greater odds of having memory or thinking problems."

Key Points: 
  • "Our study found participants who had sleep apnea symptoms had greater odds of having memory or thinking problems."
  • Of those with symptoms, 357 people, or 33%, reported memory or thinking problems compared to 628 people, or 20% of people without sleep apnea symptoms.
  • After adjusting for other factors that could affect memory and thinking problems, such as age, race, gender and education, researchers found that people who reported sleep apnea symptoms were about 50% more likely to also report having memory or thinking problems compared to people who did not have sleep apnea symptoms.
  • Additional studies are needed following people's sleep apnea, memory and thinking symptoms over time.

Tandem Cycling Linked to Improved Health for Those with Parkinson's, Care Partners

Retrieved on: 
Thursday, February 29, 2024
Social media, Television, Nervous system, Alzheimer's disease, Doctor of Philosophy, Quality of life, Walking, Stroke, Communication, Annual general meeting, DSM-IV codes, Perception, AAN, Health, Migraine, Parkinson's disease, Multiple sclerosis, University, Virtual reality, Depression, Concussion, Epilepsy, Disease, Brain, Prisma, Research, American Academy, Pharmaceutical industry

"It is just as important that care partners also receive care, so that is why we included them as the cycling partner.

Key Points: 
  • "It is just as important that care partners also receive care, so that is why we included them as the cycling partner.
  • The study included 18 participants, nine with Parkinson's disease and their corresponding nine care partners.
  • For the tandem cycling program, pairs of people with Parkinson's disease and their care partners cycled on indoor, stationary tandem bicycles while using a virtual reality platform two times per week for eight weeks.
  • The tandem cycling set-up also allowed the care partners to help adjust the cycling pace and facilitate a higher pedaling rate for greater health benefits.

New Study Finds Link Between Health Care Disparities and Stroke Treatment

Retrieved on: 
Thursday, February 29, 2024
Social media, United States census, Nervous system, Alzheimer's disease, Doctor of Philosophy, Research, Education, Kahathuduwa, Stroke, Master of Philosophy, Thrombolysis, Health, Annual general meeting, DSM-IV codes, Migraine, AAN, Multiple sclerosis, Parkinson's disease, Medicare, Employment, Concussion, Epilepsy, Medicaid, Brain, Housing, Insurance, American Academy

The study looked at people with ischemic stroke, which is caused by a blockage of blood flow to the brain and is the most common type of stroke.

Key Points: 
  • The study looked at people with ischemic stroke, which is caused by a blockage of blood flow to the brain and is the most common type of stroke.
  • The study involved 63,983 people with ischemic stroke identified through public health records in Texas.
  • Researchers then looked at social factors that may impact a person's health, such as income, education, housing, and access to health services.
  • Further studies are needed to investigate this connection between society, the health care system, and stroke outcomes.

SYNEVIT®'s Synfoline Is a Healthy Pregnancy Precaution

Retrieved on: 
Thursday, February 29, 2024
Iodine, Neural tube, Nervous system, Disability studies, Fetus, Thyroid hormones, World Health Organization, Pregnancy, Risk, Folate, Nutrient, Child, Mortality, RDA, Research, Dietary supplement

FORT LAUDERDALE, Fla., Feb. 29, 2024 /PRNewswire/ -- Pregnancy is a demanding activity. A woman's body requires unique quantities and kinds of nutrients when developing a fetus. A lack of nutrition can lead to complications and concerns for a growing child, which is why SYNEVIT® developed its Synfoline pregnancy formula.

Key Points: 
  • A lack of nutrition can lead to complications and concerns for a growing child, which is why SYNEVIT® developed its Synfoline pregnancy formula .
  • Synfoline is a clean, effective prenatal supplement designed to help both mother and child during pregnancy.
  • Neural tube defects are a concern early in pregnancy (including before a woman may realize she is pregnant), which makes Synfoline relevant in the months leading up to conception, as well.
  • "Synfoline allows you to rest in the fact that you're giving your body the nutrients it needs to do just that."

Study Finds Pesticide Use Linked to Parkinson's in Rocky Mountain, Great Plains Region

Retrieved on: 
Tuesday, February 27, 2024
Social media, Air pollution, Rocky Mountains, Nervous system, Research, Alzheimer's disease, Doctor of Philosophy, Pesticide, Barrow Neurological Institute, Record, Stroke, Risk, Annual general meeting, DSM-IV codes, Simazine, AAN, Migraine, Multiple sclerosis, Parkinson's disease, Concussion, Atrazine, Herbicide, Disease, Epilepsy, Brain, American Academy, Agriculture

In the Rocky Mountain and Great Plains region, we identified 14 pesticides associated with Parkinson's disease."

Key Points: 
  • In the Rocky Mountain and Great Plains region, we identified 14 pesticides associated with Parkinson's disease."
  • Krzyzanowski said the region included parts of Colorado, Idaho, Kansas, Montana, Nebraska, Nevada, New Mexico, North Dakota, Oklahoma, South Dakota, Texas, Utah and Wyoming.
  • They found that the pesticides and herbicides simazine, atrazine and lindane had the strongest relationship with Parkinson's disease.
  • A limitation of the study was that it relied on the use of county-level estimates since person-level information on pesticide exposure was not available for the study population.

XanEdu Announces the Release of Unlocking the Potential for Student Success

Retrieved on: 
Friday, February 16, 2024
Rewired, Nervous system, Emotion, Time management, South Mountain Community College, Education, Quality of life, Sleep, NAU, Achievement Medal, Mindfulness, Learning, Textbook, Memory, Behavioural sciences, Happiness, Glendale Community College, Science, Potential, K-12, Student, Tutoring

Unlocking the Potential for Student Success teaches the science of resilience and happiness by fostering mental well-being to improve the quality of life.

Key Points: 
  • Unlocking the Potential for Student Success teaches the science of resilience and happiness by fostering mental well-being to improve the quality of life.
  • The textbook takes a holistic approach to student success, including cognitive, emotional, social, nutritional, physical, and spiritual aspects of well-being.
  • Unlocking the Potential for Student Success was written to show students how to build resilience to be able to thrive and succeed academically.
  • After reading Unlocking the Potential for Student Success, students will:
    Enhance their well-being by tapping into the six pillars of resilience.

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Retrieved on: 
Friday, February 16, 2024
Nervous system, POC, AMIX, Collateral damage, Pain, Principal investigator, Patient, Disease, Trial of the century, Ethanol, Medical imaging

THE WOODLANDS, TX, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the completion of its site initiation for its proof-of-concept human clinical study evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain.

Key Points: 
  • “We continue to make solid progress with our PoC human clinical study.
  • This study is a very important step in validating our clinical and regulatory plans for our technology and as such our team is dedicated to its successful execution.
  • The primary objective of the proof-of-concept human clinical study is to successfully ablate relevant somatic nerves and mitigate pain in patients with pancreatic cancer pain utilizing RF ablation in a transvascular approach to the nerves in the region.
  • Twenty (20) subjects will be enrolled at one clinical trial site for the study.

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

Retrieved on: 
Wednesday, February 14, 2024
Engineering, Ethics committee, Nervous system, Research, POC, AMIX, Collateral damage, Marketing, Quality of life, Pain, Calendar, Ethics, IPO, Advertising, Launch, Completeness, Patient, Clinical trial, Disease, Pancreatic cancer, Trial of the century, Ethanol, Medical imaging

THE WOODLANDS, TX, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, reported financial results yesterday for the third quarter FY2024 ended December 31, 2023 and provided a corporate update.

Key Points: 
  • “I am incredibly pleased with the progress we have made on the corporate, financial and clinical fronts in such a short period of time.
  • We are grateful for the continued support and remain focused on successfully executing on the milestones laid out ahead of us,” commented Lori Bisson, Chief Executive Officer of Autonomix.
  • Achieving “proof-of-concept” in this area could open the door to blockbuster diseases, expanding the horizons for the Company’s technology.
  • Summary of Financial Results for Q3 FY2024 Ended December 31, 2023
    For the nine months ended December 31, 2023 and 2022, the Company incurred net losses of $10.0 million and $1.3 million, respectively.

SEALSQ Announces Groundbreaking Entry Into AI Chip Market With Advanced AIoT Strategy

Retrieved on: 
Monday, February 12, 2024
Semiconductor, Nervous system, AI, Hacking, Internet of things, Generative, Artificial intelligence of things, LAES, Learning, WIHN, Synthetic media, Safety, WKEY, Ecosystem, Post-quantum cryptography, PKI, Artificial intelligence, Customer service

SEALSQ's AIoT strategy is built on a robust foundation of semiconductors, smart sensors, IoT systems, AI technologies, and an expansive data cloud.

Key Points: 
  • SEALSQ's AIoT strategy is built on a robust foundation of semiconductors, smart sensors, IoT systems, AI technologies, and an expansive data cloud.
  • The AIoT system functions as the central brain of the expansive SEALSQ ecosystem, which currently includes over 1.6 billion semiconductor-powered devices.
  • As a leading innovator in the technology sector, SEALSQ is committed to driving digital transformation and innovation through cutting-edge solutions.
  • With its groundbreaking AIoT strategy, SEALSQ is setting new standards in the integration of AI and IoT technologies, offering secure, efficient, and transformative solutions for a rapidly evolving digital landscape.